Eurofins Scientific: Director/PDMR Shareholding
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 25 2025
0mins
Source: Businesswire
Notification of Share Transactions: Eurofins Scientific SE has reported multiple share acquisitions by Analytical Bioventures S.C.A., a company controlled by its CEO Dr. Gilles Martin, in compliance with the European Market Abuse Regulation.
Transaction Details: The transactions involved acquiring shares at various prices and volumes on different dates, with total investments amounting to over EUR 400,000 across several days in June 2025.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
